The FDA’s recommendations to improve diversity in clinical trials provide a much-needed action plan to jumpstart the changes that need to be made to ensure inclusive care, yet these recommended guidelines only scratch the surface of ideal action in clinical trials....
Attempts to prolong the life of pet dogs can help people get onboard with the idea of life extension in humans....
Providing the public with clear, understandable descriptions and results of clinical trials is imperative to fostering public trust in clinical trials and approved vaccines and treatments....
Addressing the lack of mentorship for non-white professionals is an important step to providing opportunities for candidates from all backgrounds to contribute their expertise to the clinical research workforce....
Contract Research Organization (CRO) executives share their thoughts on the top patient retention challenges facing CROs today and offer advice on potential strategies and solutions moving ahead....
Promoting a diverse clinical trial workforce is a key pillar of any effective effort to promote patient population diversity....
The clinical trial industry must be proactive and transparent in its communications with underserved communities with less access to healthcare resources and a wariness about participating in medical research....
We need a new paradigm for increasing diversity in clinical trials....
Improving the use of technology in clinical trials is now a prime opportunity for the life sciences industry. With the right tools, sponsors can enhance the efficiency of trial execution, provide patients with new ways to participate in studies, and simplify collaboration with clinical sites....
We need to widen the data net and do a better job of analyzing those data to identify clinical trials participants from previously ignored patient populations....
